These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21600161)

  • 1. [Temporal changes and interaction of serum cytokines in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention].
    Liang Y; Wang XY; Niu J; Gao W
    Zhonghua Yi Xue Za Zhi; 2011 Mar; 91(12):819-23. PubMed ID: 21600161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic changes in N-terminal pro-brain natriuretic peptide in acute coronary syndromes treated with percutaneous coronary intervention: a marker of ischemic burden, reperfusion and outcome.
    Buchner S; Debl K; Barlage S; Griese D; Fredersdorf S; Jeron A; Lubnow M; Müller T; Muders F; Holmer S; Riegger GA; Luchner A
    Clin Chem Lab Med; 2010 Jun; 48(6):875-81. PubMed ID: 20441480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline NT-proBNP and biomarkers of inflammation and necrosis in patients with ST-segment elevation myocardial infarction: insights from the APEX-AMI trial.
    van Diepen S; Roe MT; Lopes RD; Stebbins A; James S; Newby LK; Moliterno DJ; Neumann FJ; Ezekowitz JA; Mahaffey KW; Hochman JS; Hamm CW; Armstrong PW; Theroux P; Granger CB
    J Thromb Thrombolysis; 2012 Jul; 34(1):106-13. PubMed ID: 22307842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma N-terminal fragment of the prohormone B-type natriuretic peptide concentrations in relation to time to treatment and Thrombolysis in Myocardial Infarction (TIMI) flow: a substudy of the Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT IV-PCI) trial.
    Jarai R; Huber K; Bogaerts K; Droogne W; Ezekowitz J; Granger CB; Sinnaeve PR; Ross AM; Zeymer U; Armstrong PW; Van de Werf FJ;
    Am Heart J; 2010 Jan; 159(1):131-40. PubMed ID: 20102879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal changes in biomarkers and their relationships to reperfusion and to clinical outcomes among patients with ST segment elevation myocardial infarction.
    van Diepen S; Alemayehu WG; Zheng Y; Theroux P; Newby LK; Mahaffey KW; Granger CB; Armstrong PW
    J Thromb Thrombolysis; 2016 Oct; 42(3):376-85. PubMed ID: 27324144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk stratification for heart failure and death in an acute coronary syndrome population using inflammatory cytokines and N-terminal pro-brain natriuretic peptide.
    Kavsak PA; Ko DT; Newman AM; Palomaki GE; Lustig V; MacRae AR; Jaffe AS
    Clin Chem; 2007 Dec; 53(12):2112-8. PubMed ID: 17932131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-terminal pro-B-type natriuretic peptide is associated with adverse short-term clinical outcomes in patients with acute ST-elevation myocardial infarction underwent primary percutaneous coronary intervention.
    Kwon TG; Bae JH; Jeong MH; Kim YJ; Hur SH; Seong IW; Cho MC; Seung KB; Jang YS; Park SJ;
    Int J Cardiol; 2009 Apr; 133(2):173-8. PubMed ID: 18281115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between early recanalization and serum NT-proBNP levels in patients with a first ST-segment elevation myocardial infarction treated with primary coronary angioplasty.
    Szadkowska I; Goch JH; Polak L; Stepień H; Chizyński K
    Acta Cardiol; 2007 Oct; 62(5):479-84. PubMed ID: 17982969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of pretreatment with recombinant human B-type natriuretic peptide on infarct size in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].
    Li S; Fu X; Dai Y; Liu C; Wang Y; Li W; Wu W; Gu X; Hao G; Fan W; Miao Q; Jiang Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 2015 Nov; 43(11):954-9. PubMed ID: 26888806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of NT-proBNP on admission for early risk stratification of patients undergoing primary percutaneous coronary intervention.
    Ayhan E; Isık T; Uyarel H; Ergelen M; Cicek G; Ozyurtlu F; Ghannadian B; Tanboga IH
    Kardiol Pol; 2013; 71(2):165-75. PubMed ID: 23575711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased interleukin-1β levels are associated with left ventricular hypertrophy and remodelling following acute ST segment elevation myocardial infarction treated by primary percutaneous coronary intervention.
    Ørn S; Ueland T; Manhenke C; Sandanger Ø; Godang K; Yndestad A; Mollnes TE; Dickstein K; Aukrust P
    J Intern Med; 2012 Sep; 272(3):267-76. PubMed ID: 22243053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant association between admission serum monocyte chemoattractant protein-1 and early changes in myocardial function in patients with first ST-segment elevation myocardial infarction after primary percutaneous coronary intervention.
    Zhu Y; Hu C; Du Y; Zhang J; Liu J; Han H; Zhao Y
    BMC Cardiovasc Disord; 2019 May; 19(1):107. PubMed ID: 31077149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reperfusion before percutaneous coronary intervention in ST-elevation myocardial infarction patients is associated with lower N-terminal pro-brain natriuretic peptide levels during follow-up, irrespective of pre-treatment with full-dose fibrinolysis.
    Sinnaeve PR; Ezekowitz JA; Bogaerts K; Droogne W; Jarai R; Huber K; Granger CB; Desmet WJ; Armstrong PW; Van de Werf FJ;
    Eur Heart J; 2009 Sep; 30(18):2213-9. PubMed ID: 19586960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The efficacy of percutaneous coronary intervention combined percutaneous thrombectomy on coronary thrombotic lesions in patients with acute myocardial infarction].
    Yang SS; Li WM; Zhou LJ; Li Y; Wang LF; Han W; Chen YD; Zhou HY; Pan W
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Dec; 35(12):1136-40. PubMed ID: 18341818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of interleukin-6-572C/G promoter polymorphism and serum levels to post-percutaneous coronary intervention restenosis.
    Gao J; Liu Y; Cui RZ; Mao YM; Zhou J; Chen Q; Zhao FM; Yang GM
    Chin Med J (Engl); 2013 Mar; 126(6):1019-25. PubMed ID: 23506572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum NT-proBNP on admission can predict ST-segment resolution in patients with acute myocardial infarction after primary percutaneous coronary intervention.
    Peng B; Xia H; Ni A; Wu G; Jiang X
    Herz; 2015 Sep; 40(6):898-905. PubMed ID: 25997425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the usefulness of N-terminal pro-brain natriuretic peptide to other serum biomarkers as an early predictor of ST-segment recovery after primary percutaneous coronary intervention.
    Verouden NJ; Haeck JD; Kuijt WJ; van Geloven N; Koch KT; Henriques JP; Baan J; Vis MM; van Straalen JP; Fischer J; Piek JJ; Tijssen JG; de Winter RJ
    Am J Cardiol; 2010 Apr; 105(8):1047-52. PubMed ID: 20381651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma B-type natriuretic peptide level can predict myocardial tissue perfusion in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.
    Seo SM; Kim S; Chang K; Min J; Kim TH; Koh YS; Park HJ; Shin WS; Lee JM; Kim PJ; Chung WS; Seung KB
    Coron Artery Dis; 2011; 22(6):405-10. PubMed ID: 21701385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of effects of bare metal versus drug-eluting stent implantation on biomarker levels following percutaneous coronary intervention for non-ST-elevation acute coronary syndrome.
    Gibson CM; Karmpaliotis D; Kosmidou I; Murphy SA; Kirtane AJ; Budiu D; Ray KK; Herrmann HC; Lakkis N; Kovach R; French W; Blankenship J; Lui HH; Palabrica T; Jennings LK; Cohen DJ; Morrow DA;
    Am J Cardiol; 2006 May; 97(10):1473-7. PubMed ID: 16679086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized Control of Sympathetic Drive With Continuous Intravenous Esmolol in Patients With Acute ST-Segment Elevation Myocardial Infarction: The BEtA-Blocker Therapy in Acute Myocardial Infarction (BEAT-AMI) Trial.
    Er F; Dahlem KM; Nia AM; Erdmann E; Waltenberger J; Hellmich M; Kuhr K; Le MT; Herrfurth T; Taghiyev Z; Biesenbach E; Yüksel D; Eran-Ergöknil A; Vanezi M; Caglayan E; Gassanov N
    JACC Cardiovasc Interv; 2016 Feb; 9(3):231-240. PubMed ID: 26847114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.